International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows

Author(s): Brunner Scott

Issue: May/Jun 2021 - Volume 25, Number 3
View All Articles in Issue

Page(s): 206-209

FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows Page 1

FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows Page 2

FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows Page 3

FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows Page 4

Download in electronic PDF format for $75

Abstract:

Related Keywords: Alliance for Pharmacy Compounding, U.S. Food and Drug Administration, FDA, National Academies of Science, Engineering, and Medicine, NASEM report, compounded bioidentical hormone replacement, cBHT, BHRT, HRT, Pharmacy Compounding Foundation, bias, clinical utility, drug safety, advertising, promotional campaign

Related Categories: HRT, LEGAL

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows Brunner Scott	May/Jun 2021 Pg. 206-209
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Brunner Scott	Jul/Aug 2020 Pg. 296-297
PreScription: The NASEM cBHT Report, Part 1 Allen Loyd V Jr	Nov/Dec 2020 Pg. 444
NASEM Report on Compounded Topical Pain Creams Allen Loyd V Jr	Nov/Dec 2020 Pg. 446-448
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 Ford Gina, Garcia Lea	Jan/Feb 2001 Pg. 52-54
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug	Mar/Apr 2017 Pg. 95-102
Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams Allen Loyd V Jr	Sep/Oct 2020 Pg. 356
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Miller David G	May/Jun 2014 Pg. 208
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Brunner Scott	Jan/Feb 2023 Pg. 22-23
PreScription: The NASEM cBHT Report, Part 2 Allen Loyd V Jr	Jan/Feb 2021 Pg. 4
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G	Jul/Aug 2015 Pg. 303-305
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1 DeRosa Angela	Nov/Dec 2020 Pg. 466-470
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 2 DeRosa Angela	Jan/Feb 2021 Pg. 14-17
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr	Sep/Oct 2015 Pg. 389-390
IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities Miller David G	Mar/Apr 2014 Pg. 117-118
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J	Jul/Aug 2004 Pg. 313-319
Return to Top